Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
NK cells in therapy of cancer
Veronika Bachanova
,
Jeffrey S. Miller
Medicine - Hematology, Oncology, Transplant
Transplant and Cellular Therapy
Cancer Immunology
Research output
:
Contribution to journal
›
Article
›
peer-review
99
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'NK cells in therapy of cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Natural Killer Cells
100%
CD16
33%
Bispecific
16%
Regulatory T Cells
16%
Malignant Transformation
16%
Haploidentical
16%
Interleukin-2
16%
Tumor Antigen
16%
Interleukin-15 (IL-15)
16%
Engager
16%
Treg
16%
Clinical Treatment
16%
Natural Killer Cell Therapy
16%
Trispecific
16%
Metalloproteinases
16%
Natural Killer Cell Activity
16%
Major Histocompatibility Antigen
16%
Histocompatibility Antigens Class I
16%
Lymphodepleting Chemotherapy
16%
Long-lived
16%
In Vivo Survival
16%
Treat Cancer
16%
Gain Function
16%
Immunology and Microbiology
Natural Killer Cell
100%
Regulatory T Cell
25%
CD16
25%
Cytokine
25%
Infectious Disease
12%
Interleukin 2
12%
Cell Activation
12%
Major Histocompatibility Antigen
12%
Interleukin 15
12%
Tumor Antigen
12%
Infection
12%